← FDA Drug Approvals (Drugs@FDA)
TESTOSTERONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2020-11-25
Drug application
- FDA Application #
ANDA209181- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TESTOSTERONE
- Generic name
- Testosterone
- Active ingredients
- TESTOSTERONE
- Dosage form
- SOLUTION, METERED
- Route
- TRANSDERMAL
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2020-11-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown